Qingchun Fu
Overview
Explore the profile of Qingchun Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillessen A, Angelico F, Chen J, Lu L, Lucena M, Fu Q, et al.
Gastro Hep Adv
. 2024 Aug;
1(5):882-893.
PMID: 39131840
Chronic liver disease (CLD) is a leading health problem impacting the quality of life globally. China shares a major global burden of CLD-including alcoholic liver disease, nonalcoholic fatty liver disease/metabolic...
2.
Jin Y, Shi R, Qi T, Li Q, Chen C, Gao S, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2023 Apr;
55(4):601-612.
PMID: 37078751
Hepatocyte transplantation contributes to the repair of liver damage, but hepatocyte resources are limited, making it difficult for this to become a routine treatment. Previous studies have confirmed that mesenchymal...
3.
Wu B, Feng J, Guo J, Wang J, Xiu G, Xu J, et al.
Stem Cell Res Ther
. 2022 Oct;
13(1):494.
PMID: 36195966
Background: Hepatic fibrosis is a common pathologic stage in chronic liver disease development, which might ultimately lead to liver cirrhosis. Accumulating evidence suggests that adipose-derived stromal cells (ADSCs)-based therapies show...
4.
Li Q, Li W, Jin Y, Xu W, Huang C, Li L, et al.
Infect Dis Ther
. 2020 Sep;
9(4):823-836.
PMID: 32880102
Objectives: This study aimed to observe the efficacy of corticosteroids in non-severe COVID-19 pneumonia. Methods: A retrospective study based on propensity score matching was designed to explore the effects of...
5.
Fu X, Qie J, Fu Q, Chen J, Jin Y, Ding Z
Front Oncol
. 2020 Mar;
10:107.
PMID: 32117757
Combined inhibition of programmed death-ligand 1 (PD-L1) and transforming growth factor-β (TGF-β) displayed additive anti-tumor response in a subgroup of cancer patients, highlighting the importance of understanding the multifaceted roles...
6.
Wang L, Zhu M, Cao L, Yao M, Lu Y, Wen X, et al.
J Clin Transl Hepatol
. 2020 Jan;
7(4):313-321.
PMID: 31915600
Non-invasive evaluation of liver necroinflammation in patients with chronic liver disease is an unmet need in clinical practice. The diagnostic accuracy of transient elastography-based liver stiffness measurement (LSM) for liver...
7.
Ni J, Li H, Zhou Y, Gu B, Xu Y, Fu Q, et al.
Cell Physiol Biochem
. 2018 Aug;
48(4):1710-1722.
PMID: 30077997
Background/aims: To evaluate whether local injection of exosomes derived from human adipose-derived stem cells (hADSCs) facilitates recovery of stress urinary incontinence (SUI) in a rat model. Methods: For the in...
8.
Jin Y, Wang J, Li H, Gao S, Shi R, Yang D, et al.
EBioMedicine
. 2018 Aug;
34:231-242.
PMID: 30077720
It has previously been reported that human adipose-derived stem cells (hASCs) can promote the regeneration of damaged tissues in rats with liver failure through a 'paracrine effect'. Here we demonstrate...
9.
Cao X, Gao Y, Zhang W, Xu P, Fu Q, Chen C, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2015 Oct;
23(8):569-73.
PMID: 26447618
Objective: To investigate the epidemiological status of cholestasis in first-hospitalized patients with chronic liver disease in Shanghai, and to provide a scientific basis for developing prevention and treatment measures. Methods:...
10.
Chen G, Jin Y, Shi X, Qiu Y, Zhang Y, Cheng M, et al.
Stem Cell Res Ther
. 2015 Apr;
6:40.
PMID: 25890008
Introduction: Acute liver failure (ALF) is a highly lethal disease, for which effective therapeutic methods are limited. Although allogeneic liver transplantation is a viable treatment method for ALF, there is...